Press Release

Hatch Medical’s Advanced Retrieval Device Receives FDA Approval

Atlanta , Georgia – Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, today announced that Medical Device Technologies, Inc. (MD TECH), a member of The Marmon Group of companies, has received U.S. Food and Drug Administration (FDA) clearance for its novel foreign body retrieval device, EN Snare®. Under terms of a prior agreement, MD Tech will manufacture and globally distribute the product through its direct sales force and distributor network.

John Kaufman, M.D., Professor, Dotter Interventional Institute, Oregon Health Sciences University, who performed the initial clinical studies on EN Snare®, commented, “Hatch Medical's EN Snare® is the most important advance in foreign body retrieval devices in over a decade. During our clinical work the device demonstrated exceptional utility in a variety of endovascular applications. The forward-looking multi-loop design is unique, providing rapid, secure engagement of a wide variety of objects. Opening of the loops is predictable and easily controlled by the physician, allowing precise and definitive ensnarement.”

Hatch Medical’s EN Snare® foreign body retrieval device incorporates proprietary technology and design elements that improve upon the overall utility, accuracy and simplicity of foreign body retrieval. As a result, EN Snare® is ideally suited to address the needs of physicians performing complex endovascular procedures in the peripheral vascular system and hollow viscous. It is estimated that over 75,000 foreign body retrieval procedures will be performed in 2002 by cardiologists, vascular surgeons, radiologists, gastroenterologists and urologists around the globe.

Michael Ryan, Vice President of Sales and Marketing for Medical Device Technologies, Inc., commented, “Now that we have received regulatory approval, we look forward to an early launch of EN Snare® and significant success in the market with this state of the art product.”

Paul Gianneschi, President and CEO of Hatch Medical, L.L.C. added, “This is yet another important milestone for our organization and continues to demonstrate the value Hatch Medical delivers to its clients, partners and affiliates around the world. We look forward to assisting MD Tech with the launch of EN Snare® and cheering their success in the market.”

The Marmon Group of companies is an international association of autonomous manufacturing and service companies. Collective sales in 2000 reached $6.8 billion.

Hatch Medical jointly develops and brokers minimally invasive medical devices for the diagnosis and treatment of peripheral vascular, cardiovascular and oncological disease states through its network of product development experts.

For additional information on this, or other Hatch Medical, L.L.C. products and services, e-mail the company at info@hatchmedical.com. This release and additional news about Hatch Medical can be obtained by visiting the company’s web site at: http://www.hatchmedical.com.

Contact Paul Gianneschi, President and CEO, 770-982-6306, or Steve Hvozda, Executive Vice President, Business Development 404-982-9994.

Hatch Medical, L.L.C.
8750 Islesworth Court
Duluth, GA 30097
Phone: 770-476-9940
Facsimile: 770-476-7740
info@hatchmedical.com